OTCMKTS:PARNF

Parnell Pharmaceuticals Stock Forecast, Price & News

$0.37

0.00 (-0.67 %)

(As of 01/15/2021 08:27 PM ET)

Add

Compare

Today's Range

$0.37

Now: $0.37▼

$0.38

50-Day Range

$0.30

MA: $0.35▼

$0.39

52-Week Range

$0.04

Now: $0.37▼

$0.40

Volume30,000 shs

Average Volume27,866 shs

Market Capitalization$7.40 million

P/E RatioN/A

Dividend YieldN/A

Beta5

Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product aids in the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also operates mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Overall MarketRank^™

0.54 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Parnell Pharmaceuticals.

2.7 Community Rank

Outperform Votes
Parnell Pharmaceuticals has received 109 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Parnell Pharmaceuticals has received 94 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Parnell Pharmaceuticals has received 53.69% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Parnell Pharmaceuticals and other stocks. Vote “Outperform” if you believe PARNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PARNF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Parnell Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Parnell Pharmaceuticals does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Parnell Pharmaceuticals insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:PARNF

Previous SymbolNASDAQ:PARN

CUSIPN/A

CIKN/A

Webwww.parnell.com

Phone61-2-9667-4411

EmployeesN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares20,000,000

Market Cap$7.40 million

Next Earnings DateN/A

OptionableNot Optionable

$0.37

0.00 (-0.67 %)

(As of 01/15/2021 08:27 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive PARNF News and Ratings via Email

Sign-up to receive the latest news and ratings for PARNF and its competitors with MarketBeat's FREE daily newsletter.

Parnell Pharmaceuticals (OTCMKTS:PARNF) Frequently Asked Questions

How has Parnell Pharmaceuticals' stock price been impacted by COVID-19?

Parnell Pharmaceuticals' stock was trading at $0.1001 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PARNF stock has increased by 269.6% and is now trading at $0.37.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Parnell Pharmaceuticals?

Wall Street analysts have given Parnell Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Parnell Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Parnell Pharmaceuticals?

Parnell Pharmaceuticals saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 4,500 shares, an increase of 87.5% from the December 15th total of 2,400 shares. Based on an average trading volume of 55,300 shares, the days-to-cover ratio is presently 0.1 days.
View Parnell Pharmaceuticals' Short Interest.

Who are some of Parnell Pharmaceuticals' key competitors?

Some companies that are related to Parnell Pharmaceuticals include Hoth Therapeutics (HOTH), EyeGate Pharmaceuticals (EYEG), IntelGenx Technologies (IGXT), Can-Fite BioPharma (CANF), InMed Pharmaceuticals (INM), Provectus Biopharmaceuticals (PVCT), Adial Pharmaceuticals (ADIL), Emerald Bioscience (EMBI), Midatech Pharma (MTP), Vicapsys Life Sciences (VICP), RespireRx Pharmaceuticals (RSPI), China SXT Pharmaceuticals (SXTC), Integrated BioPharma (INBP), Salarius Pharmaceuticals (SLRX) and Bioxytran (BIXT).
View all of PARNF's competitors.

Who are Parnell Pharmaceuticals' key executives?

Parnell Pharmaceuticals' management team includes the following people:

Dr. Alan Richard Bell, Exec. Chairman (Age 65)
Mr. Brad R. McCarthy, CEO, CFO, Chief Accounting Officer, Company Sec. & Exec. Director (Age 45)

What is Parnell Pharmaceuticals' stock symbol?

Parnell Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PARNF."

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Parnell Pharmaceuticals' stock price today?

One share of PARNF stock can currently be purchased for approximately $0.37.

How big of a company is Parnell Pharmaceuticals?

Parnell Pharmaceuticals has a market capitalization of $7.40 million.

What is Parnell Pharmaceuticals' official website?

The official website for Parnell Pharmaceuticals is www.parnell.com.

How can I contact Parnell Pharmaceuticals?

Parnell Pharmaceuticals' mailing address is UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD, ALEXANDRIA C3, 2015. The company can be reached via phone at 61-2-9667-4411 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here